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Introduction: Measurement of health care performance is important for quality assurance 
and improvement of health services. With regular monitoring and follow-up, unwarranted 
variations in performance can be reduced. For performance measurement to have the desired 
effects, meaningful indicators of performance need to be selected, methods that ensure 
comparability between hospitals need to be employed, and information must adequately be 
fed back to providers and professionals. Birth care is one of the most common causes of 
hospitalisation and large variations in practice have been observed which highlights the 
relevance of performance measurement in this area. More knowledge is needed on how to use 
indicators and appropriate methods for measurement of performance and how this 
information can be used to improve clinical practice.  
Aim: The overall aim of this thesis is to show how routinely collected data can be used to 
measure health care performance in the area of birth care and to assess how such 
measurement can support quality improvement. 
Method: Three of the four studies are based on quantitative analyses of a research database 
with extensive information on patient characteristics, care process, resource use, and health 
outcomes for almost 140 000 women giving birth. Regression analyses were employed to 
investigate the importance of case mix adjustment and the variations in performance between 
Swedish birth clinics. The fourth study is based on interviews with managers and staff in a 
hospital department to understand how they perceived the use of technology for feedback of 
performance data in improvement efforts. 
Findings: Patient characteristics have a significant effect on birth care performance 
indicators and adjustment for differences in patient populations is a prerequisite for 
meaningful performance measurement. There are large variations in case mix adjusted 
performance between birth clinics in Sweden in terms of both the care process and the health 
outcomes achieved. If all clinics performed as the top 20%, around 2200 caesarean sections 
would be avoided annually in the regions studied. Similarly, almost 900 perineal tears of 
grade 3 or 4 and 1500 post-partum infections would be avoided. There are a number of 
factors that facilitate or hinder the adoption of technology for timely feedback of relevant 
performance data. Managers and staff perceive that such feedback of data supports quality 
improvement.  
Conclusions: Adjustment for patient characteristics is a prerequisite for meaningful 
comparisons of performance between hospitals and can be used to analyse unwarranted 
variations. Analysis of case mix adjusted variations in performance between Swedish birth 
clinics reveals significant potential for improvement of outcomes and reduced costs. 
Continuous use of performance data can support quality improvement and lead to reduced 
variations in performance.  
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1 BACKGROUND 
 
1.1 THE CHALLENGE FOR HEALTH CARE  
Human health has improved tremendously over a long period of time, with life-expectancy 
and quality of life increasing dramatically world-wide: “The 20th century has seen a global 
transformation in human health unmatched in history.”[1] This development is in part due to 
rapid advancements in medicine and the provision of health care during the last hundred 
years. While health care is still continuously improving at a high pace, there are concerns 
over large variations in care practice and the increasing costs associated with health care 
provision. Today, we have a situation where costs of health care have been rising in most 
countries for several decades and are projected to increase further during the coming years. 
This development has been explained by factors such as demographic trends, new 
technologies, and increasing demands but the increase in health care costs has also been 
attributed to inappropriate use of medical services and unwarranted variations in clinical 
practice [2, 3].  
Recent evidence suggests that both overuse and underuse of medical services are fundamental 
problems in health care delivery worldwide. For example, the rate of inappropriate total 
knee replacement rates has been estimated at 26% in Spain and 34% in the United States, 
and rate of inappropriate percutaneous coronary interventions and coronary angiography in 
Italy has been estimated to 22% and 30%, respectively [4]. The WHO has estimated that 
each year 6.2 million excess caesarean sections are performed worldwide [5]. Underuse of 
available medical services also contributes to substantial costs and patient harm. This is 
caused by limited access and availability of services, as well as failure of providers to deliver 
services and failure of patients to use them [6]. Research suggests that the average time for 
research evidence to reach clinical practice is 17 years [7]. One widely cited example of the 
slow diffusion of best practice in health care is a study by Eisenberg et al., which observed 
large variations in use of evidence-based medical therapy in patients undergoing 
percutaneous coronary revascularization in both the United States, Canada and Europe, and 
which found significant deviations from treatment guidelines [8]. 
The term “unwarranted variation” in health care has been attributed to John Wennberg [9]. 
As opposed to warranted variation, which are differences that can be attributed to the needs 
of the population served, unwarranted variation is defined as variations in the utilisation of 
health care services that cannot be explained by differences in patient characteristics or 
patient preferences. Unwarranted variations in health care have been pointed out as a major 
obstacle to achieving an effective health system where resources are put to the best possible 
use: “Unwarranted variation is unacceptable: it wastes resources, and it is the hallmark of 
poor-quality and lower-value healthcare. Investigating the causes of variation offers the 
opportunity of identifying and eliminating lower-value activity.” ([10], p 20) 
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1.2 PERFORMANCE MANAGEMENT 
The fundamental goal of health systems is to improve the health of patients and citizens. The 
objective of performance measurement in health care is to evaluate and communicate to what 
extent the health care systems meet these key objectives. This often includes aspects such as 
health status achieved, responsiveness to patient preferences, and efficiency in the use of 
health care resources [11]. Ideas about organizational performance are largely rooted in a 
rationalist and mechanistic model of organizations. Given the large complexity of health 
systems and the number of stakeholders involved, analysis and management of organizational 
performance is challenging. However, performance management in health care has been 
gaining momentum due to a multitude of different factors such as decreased information 
asymmetry between different stakeholders in the systems, changes in social norms, the 
enormous development of IT systems for collection and analysis of data, and the increasing 
awareness of unacceptable variations in performance [12]. The importance of systematic 
analysis of performance and health system functioning is well phrased by the frequently 
quoted words of Donald Berwick: “Every system is perfectly designed to achieve the results 
it achieves” [13].  
 
Figure 1 An analytic framework for performance management. Source: Adapted from Walshe [12] 
 
Figure 1 presents a framework for performance management in health care. The 
organizational objectives are shaped both by the organization’s stakeholders (such as patients, 
providers and payers) and by the wider environment (such as societal norms, economic, and 
political drivers). The dotted box describes the organization’s functioning which consists of 
inputs (including facilities, human capital, knowledge, and information), processes (the way 
in which health care is delivered), and outputs (both in terms of number of patients treated, 
the volume of patient contacts, and also the outcomes achieved for those patients – such as 
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reduced morbidity and mortality, and improved health status and functioning). The 
Donabedian model for evaluating quality of care, which will be used in this thesis to classify 
performance indicators, categorizes performance measures into indicators of structure 
(Inputs), care processes (Processes), and outcomes (Outputs) [14]. Performance indicators 
and measurement systems serve to analyse the organizational performance in terms of both 
inputs, processes, and outputs, while performance management systems are mechanisms put 
in place to use indicators to influence the organization to change and improve.  
1.3 HEALTH CARE PERFORMANCE MEASUREMENT AND IMPROVEMENT 
The practice of performance measurement is not a new phenomenon. There is evidence of 
collection of patient outcome data more than 250 years ago and already in the early 1900s 
Ernest Codman proposed a detailed system of follow-up, identification of best surgeons 
based on the actual results of their care, and interhospital comparisons [15]. However, given 
current demographic trends, increasing availability of technology, and increasing complexity 
of health systems, the need for improved performance measurement and transparency is as 
great as ever. Examples of large-scale initiatives for monitoring of performance and 
variations in health care include the Dartmouth atlas of health care in the United States [16], 
the NHS Atlas of Variation in Healthcare in the UK [10], and also Open comparisons (Öppna 
jämförelser) in Sweden [17]. 
Systematic analysis of hospital performance offers opportunities for identification of best 
practice and for clinical improvement. However, there is no automatic link between 
performance measurement and improvement in care provided by health care professionals. 
Several different possible methods (which can obviously be combined) for achieving clinical 
improvement through performance measurement have been discussed in the international 
literature and are presented below. 
1.3.1 Accreditation and recertification 
Performance measurement may be used as a requirement in accreditation of provider 
institutions and recertification of individual providers. In the United States, the NCQA and 
Joint Commission are two major accreditors who systematically collect performance data 
from both health plans and hospitals [18]. Since 1999, the International Society for Quality in 
Health Care also has an international programme that provides accreditation in over 40 
countries for regulatory bodies and for organizations that perform accreditation and 
certification [19]. Owing to the wide variation in accreditation and certification and the 
complex context in which it is performed, there is a relative scarcity of evidence of its impact. 
There are, however, studies indicating that accreditation and certification does have a positive 
impact on clinical practices in several cases [20]. 
1.3.2 Public reporting 
Public reporting of performance data is increasingly being used to drive health care 
improvement, with certain evidence that transparency around hospital performance to the 
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general public can improve quality. One commonly mentioned example of this is widely 
available risk-adjusted mortality rates following coronary artery bypass grafting (CABG) in 
the United States [21].  
Berwick et al. [22] have investigated the link between reporting of health care performance 
data and quality improvement and discuss two possible mechanisms: Improvement through 
selection and improvement through changes in care. Improvement through selection works 
by patient flows reacting to the reported performance data. There are several different 
potential ways for patient flows to be affected by reporting of data, including individual 
patient choice, selective contracting by health care payers, or selective referrals by providers. 
Hence, this pathway can improve quality by getting the best out of the current distribution of 
performance. The second pathway, on the other hand, works by impacting the actual 
underlying distribution of performance. In the changes in care pathway, improved 
performance is achieved by altering behaviour and processes among those responsible for 
health care provision. While there is limited evidence for the selection pathway, there is a fair 
amount of evidence supporting the changes in care pathway [23]. 
1.3.3 Pay for performance 
Tying financial incentives to performance has also been widely employed to improve health 
care delivery. Conrad [24] describes several different dimensions along which financial 
incentives may vary, such as: 
• The nature of incentive (reward or penalty) 
• The target entity (group or individual) 
• The type of incentive (general or specific) 
• The magnitude of the incentive 
• The certainty around incentive levels 
• Frequency and duration of incentives (short-term or long-term) 
There is an abundance of literature on the topic of linking financial incentives to 
performance. While “[t]here is no doubt that clinicians and other actors in the health system 
generally respond as expected to financial incentives” ([11], p 675), the evidence has been 
mixed on the exact effect of different financial incentives that have been put into practice. 
This should not come as a surprise given the enormous number of possible permutations of 
different design aspects described above. In fact, the topic of payment for performance has 
received such widespread interest in the literature that systematic reviews of systematic 
reviews have been conducted [25].  
1.3.4 Clinical audit, feedback and quality improvement 
The practices of accreditation and recertification, public reporting, and pay for performance 
described above can be described as mechanisms through which governmental actors and 
payers impact providers through regulation, provider selection, and financial incentives. 
However, performance measurement can also be used to stimulate efforts for continuous 
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improvement and development. Many believe that measurement is better used for learning 
rather than for selection, reward, or punishment [13]: “[T]here will be no predictable and 
systematic progress in improving quality unless these professionals become engaged in 
collecting and using performance data to effect change” ([18], p 613). Providers may be more 
willing to change their practice if they receive feedback showing that they perform below 
some established benchmark or the norm. The practices of audit and feedback investigated in 
the literature have to a large extent been in the form of feedback to individual health care 
professionals on their performance relative to other professionals. The results of interventions 
involving this type of audit and feedback have been mixed and many different factors may 
impact their effect, including the baseline performance, the format of feedback (e.g. verbal or 
written), the source of feedback (e.g. supervisor or colleague, employer), the frequency of 
feedback, the profession of the recipient, and also whether feedback is accompanied by 
instructions for improvement and action plans [26]. 
Beyond feedback to individual professionals, measurement and feedback of performance is 
also an integral part of quality improvement (QI). QI has been defined as the combined and 
unceasing efforts of everyone to make changes that lead to better patient outcomes, better 
system performance and better professional development [27]. Most health care organizations 
claim to consistently engage in QI, but few QI efforts manage to consistently improve and 
sustain improvements over time [28].  
Data is a fundamental component of QI, both in terms of informing where there is potential 
for improvement, offer a motivation for change, and to provide measurements that allow for 
evaluating the impact of implemented changes to care practice [27]. However, there are many 
characteristics of performance data that impact their usefulness for driving QI. One aspect 
that has been identified is timeliness of feedback. In a systematic review of how medical 
registries provide feedback to providers, van der Veer et al. found that timeliness of feedback 
from registers varied substantially, with time lags up to three years [29]. A systematic review 
of the application of the PDSA cycle for QI observed that a large majority of studies did not 
have access to data at monthly or more frequent intervals. As a consequence, it was not 
possible to continuously evaluate change [30]. Another critical aspect is data quality, with 
several studies observing that trust by users in the quality of the data used for feedback is of 
utmost importance [29, 31]. As discussed in section 1.4.2, adjustment for case mix has also 
been identified as an important factor for providing effective feedback [29, 31]. 
1.3.5 Potential risks associated with performance measurement 
There are several potential pitfalls related to the use of performance measurement. While 
some of these are clearly dependent on how the measurement is used to improve 
performance, there are some general themes in the literature. Potential risks have most 
frequently been discussed in relation to public reporting of performance data and when 
linking financial incentives to performance measures. 
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One potential risk with performance measurement that has been raised is that actors in the 
systems may be inclined to game data to receive financial gains or good results in public 
report cards. This gaming may include miscoding of diagnoses or excessive coding of 
comorbid conditions [23, 24]. 
Another factor that should be considered is the fact that focus on a certain number of 
indicators can lead to excessive emphasis on the specific indicators being measured and 
consequently that indicators not being measured could get ignored. There is certain evidence 
that the incentivization of specific measures may lead to a deterioration in un-incentivized 
measures. However, there is also some evidence that incentivization of certain measures can 
lead to positive spillover effects onto other measures [25].  
Another issue that has been evoked in the literature is that performance measurement could 
lead to adverse selection of patients caused by providers having incentives to treat patients 
with better pre-requisites. This topic has been investigated extensively, not least in relation to 
the public reporting of mortality rates following CABG discussed above. While the 
conclusions from those investigations partially conflict, there have been reports that this 
public reporting led physicians to selecting patients with lower risk and that the access to care 
for severely ill patients was decreased [18, 23]. 
A potential risk associated with tying financial incentives to performance is that extrinsic 
incentives, such as financial ones, may crowd out intrinsic incentives (individuals’ inner 
motivation to perform well).  For that reason, the financial incentives should optimally be as 
aligned as possible with the inner motivation of the health care professionals [24, 25].  
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1.4 METHODOLOGICAL ASPECTS OF PERFORMANCE MEASUREMENT 
 
1.4.1 Selection and classification of indicators 
Identification of relevant indicators of performance is a fundamental component for 
meaningful measurement. Indicators are “succinct measures that aim to describe as much 
about a system as possible in as few points as possible” ([32], p 5). Indicators of performance 
measurement are often divided into three broad categories, following the Donabedian model 
[14, 33]: 
 
Figure 2 Description of the Donabedian model for measuring quality of care 
Traditionally, performance measurement has focused on process indicators to a larger extent 
than outcomes that matter to patients [34]. Indicators of the care process are very relevant to 
measure adherence to guidelines and best practice. These indicators are also more directly 
impacted by the provider than patient health outcomes [35]. However, care process indicators 
do not have the same intrinsic value to patients as do indicators of health outcome and they 
also don’t reflect the fundamental goal of the health system. Historically, outcomes 
measurement has largely focused on objective clinical endpoints, but the last decades have 
seen an increasing interest in the use of patient-reported outcome measures (PROMs) [34, 
36]. Initiatives are also being taken to standardize outcome measures internationally for 
increased transparency and possibilities of benchmarking [34].  
To ensure relevance of indicators in terms of capturing health care quality, the following 
criteria for selection of performance measures have been proposed by the Institute of 
Medicine [33]: 
• Scientifically sound: The measure should be reliable and valid 
• Feasible: The measure should be possible to collect without too high burden of 
measurement 
• Important: The measure should be important in terms of health or resource use 
• Alignment: The measure should optimally be aligned with existing measures to 
reduce redundancy and burden of reporting 
• Comprehensiveness: The selected measures should jointly address the way the care is 
delivered and the quality 
 
As described above, adjustment for patient characteristics is also important to ensure 
reliability and relevance performance measurement.  
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1.4.2 Adjustment for differences in case mix 
One obstacle in many previous initiatives for analysis of variations in health care has been 
their failure to deal with the differences in the patient population across regions and hospitals. 
This has led to discussions around whether variations are actually warranted and caused by 
variations in underlying patient characteristics. To overcome this, adjustment for case mix 
(sometimes also called risk adjustment) has been proposed. Case mix adjustment is a 
statistical method which allows data to be modified to control for variations in patient 
populations, making it possible to take these differences into account when resource use and 
health outcomes are compared, thereby allowing for “apples-to-apples” comparisons [33]. In 
cases where financial incentives are linked to performance measures, case mix adjustment 
can remove the incentives of selecting “easier” patients for treatment (cream skimming). 
When using performance measures are used for benchmarking, failure to adjust for 
differences in patient populations can hamper attempts to engage providers in meaningful 
dialogue about the potential for improving performance. In the absence of case mix 
adjustment, discussions with providers tend to centre around the unfairness of unadjusted data 
and the inability of data to reflect the underlying characteristics of their patients. This 
phenomenon has been dubbed the “my patients are sicker” syndrome [29]. Case mix 
adjustment aims at distinguishing factors that clinicians can control from factors that are 
outside their control, such as underlying patient characteristics, to understand actual 
performance and to stimulate discussions around improvement strategies [37]. A study 
performed in maternity units in England has concluded that use of benchmarking data for 
clinical improvement is contingent on data being reliable and adequately adjusted for 
differences in case mix [31].  
Despite case mix adjustment being widely accepted and increasingly used, methodological 
advancements are still needed. However intuitive case mix adjustment may sound, “[t]his 
straightforward purpose belies the complexity of devising clinically credible and widely 
accepted risk adjustment methods, especially when resulting performance measures might be 
reported publicly or used to determine payments” ([37], p 251). 
1.5 CHALLENGES TO THE USE OF TECHNOLOGY FOR PERFORMANCE 
MEASUREMENT  
The cover page of this thesis shows how the Akademiska University Hospital in Uppsala 
manually followed up their birth care in 1978 using a ballpoint pen and a notebook. One 
important driver for increased use of performance measurement is the technological 
transformation of our ability to capture, process, analyse and present data. The amount of data 
generated in all sectors of society is growing exponentially, with health care being one of the 
fastest-growing segments. A report from 2014 estimated that the total amount of data in the 
health care sector would increase from 153 exabytes in year 2013 to 2314 exabytes in year 
2020 [38]. From a situation where health care documentation was completely paper-based, it 
is now possible to gather huge volumes of patient level data from different sources such as 
digital clinical records, other routine data sources and surveys. In addition to increasing 
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amounts of data being available, the capacity of processing data has advanced dramatically 
and techniques for making sense out of heterogeneous and complex data sets for 
measurement of performance have also improved [12]. 
However, despite the incredible technological advancements made over the last decades, 
healthcare has struggled to fully adopt technical innovations and make them an integral part 
of health care delivery. This problem may arise from a variety of different reasons, such as 
unwillingness of patients and providers to use the technology or difficulties in integrating 
with pre-existing technological solutions and established routines. Even when new 
technology is adopted, there are challenges associated with abandonment by individuals, or 
failure to scale up, spread and sustain innovations [39]. An explanation for this problem is 
that health care is becoming increasingly complex, with a multitude of different agents whose 
acts and interactions within a changing context are not predictable [40]. The inherent 
complexity of implementing technology in this health care setting is often underestimated. To 
enable a systematic assessment of barriers to adoption of technology in terms of complexity, 
Greenhalgh et al. developed the NASSS (Non-adoption or Abandonment of technology by 
individuals and difficulties achieving Scale-up, Spread and Sustainability) framework to help 
predict and evaluate the success of a technology-supported health care programme [39, 41]. 
 
Figure 3 The NASSS framework for considering influences on the adoption, non-adoption, abandonment, spread, scale-up 
and sustainability of health and care technologies. Image reproduced with permission 
(https://creativecommons.org/licenses/by/4.0/) from Greenhalgh et al. BMC Medicine (2018) 16:66. 
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As illustrated in Figure 3, the framework consists of seven domains, each with several 
subdomains. Each domain can be classified as simple (“straightforward, predictable, few 
components”), complicated (“multiple interacting components or issues”) or complex 
(“dynamic, unpredictable, not easily disaggregated into constituent components”). 
Technology-supported innovations face particular challenges in situations where there is a 
high degree of complexity in a large number of these domains:  
1. Condition: Concerns the nature or characteristics of the illness that the technological 
innovation addresses. 
2. Technology: Refers to the material and technical complexity of the innovation used, 
such as its design, the data it generates, ease of use, and also questions of how it fits 
with pre-existing technology and intellectual property. 
3. Value proposition: Relates to the value of the innovation both from the supply-side 
(revenue for the developer) and the demand-side (strong evidence that the technology 
is desirable and adds value). 
4. Adopter system: Concerns the need for intended adopters to learn new skills and take 
on new roles. The domain also includes patients’ or their caregivers’ knowledge and 
identity in innovation adoption. 
5. Organization: Relates to the organization’s readiness to adopt new technology, how 
the decision to implement the technology into the organization was made and how 
that decision was motivated. Disruptions to established work routines and the amount 
of work required to adopt the new technology can also affect organizational response. 
6. Wider system: Refers to the broader context in terms of policy, finance, the 
regulatory setting, and whether the legal status of new technology is unclear. This 
domain also includes the involvement of professional bodies as well as networking 
and knowledge sharing between organizations.  
7. Embedding and adaptation over time: Refers to the possibility to adapt and 
coevolve technology and organizations using the technology to changing external 
conditions over time. 
Use of technology for performance measurement and data-driven QI may involve complexity 
in all of the domains above and the framework provides a useful structure to understand 
under what circumstances technology-enabled performance measurement is more likely to 
succeed.  
1.6 PERFORMANCE MEASUREMENT AND VARIATIONS IN CHILDBIRTH 
CARE 
Pregnancy and childbirth is one of the most common causes for hospitalization in Europe 
[42] and giving birth constitutes an important event in most people’s lives. The large volumes 
of childbirth care and the associated costs, coupled with observed variations in practices and 
outcomes, nationally and internationally, make childbirth care an extremely relevant area for 
performance measurement. 
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1.6.1 Selection of indicators 
In international comparisons of health system performance, maternal and neonatal mortality 
constitute the most widely used quality indicators of maternity care. However, in developed 
countries rates of maternal and neonatal mortality are low. In Sweden, the rate of neonatal 
mortality was 1.6 cases per 1000 live births in 2015, while the rate of maternal mortality was 
as low as 4 cases per 100 000 live births [43]. While these are still fundamental indicators to 
improve further, they need to be complemented with additional indicators of quality and 
performance to reflect the level of maternal care provided. In the words of the WHO 
Assistant Director-General for Family, Women, Children and Adolescents in 2018: “To meet 
Sustainable Development Goal 3 of ensuring healthy lives and promoting well-being for all at 
all ages, we cannot keep our focus solely on survival. High quality care for all pregnant 
women and their newborns, throughout pregnancy, childbirth and the postnatal periods, is 
essential to ensure that mothers and children both survive and thrive.”[44] 
Numerous international and national organizations have developed recommendations for 
indicators to be used for quality assessment of maternity care. Escuriet et al. [45] provide an 
overview of proposed performance indicators throughout maternity care. The 10 most 
frequently measured events they identified in the literature are summarized below: 
1. Caesarean section  
2. Vaginal delivery with instrument (type of instrument) 
3. Maternal postnatal complications  
4. Perineal tears  
5. Method of infant feeding  
6. Induction and augmentation of labour  
7. Vaginal delivery without instruments (may include normal birth) 
8. Apgar score 
9. Other neonatal complications  
10. Mode of labour onset 
The European Board and College of Obstetrics and Gynaecology (EBCOG) [46] have 
proposed the following set of indicators for assessment of intrapartum care: 
1. Percentage of induction of labour  
2. Mode of delivery by age groups and parity (spontaneous, operative vaginal, elective 
and emergency CS) 
3. Percentage of women by parity receiving augmentation of labour with oxytocin 
infusion 
4. Percentage of women by parity having episiotomy 
5. Percentage of women by parity having grade three or grade four perineal tears 
6. Rate of intrapartum stillbirths  
7. Percentage of newborns with Apgar score below 7 at 5 minutes 
8. Percentage of babies born with weight less than 1500 grams  
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9. Percentage of neonatal deaths attributable to congenital anomalies 
10. Percentage of women with postpartum haemorrhage of 1000 ml or more and/or 
requiring transfusion 
11. Percentage of women allowed trial of vaginal birth following previous caesarean 
section 
12. Rate of women having emergency caesarean hysterectomy for severe postpartum 
haemorrhage 
13. Rate of women requiring intensive care unit admission following delivery  
14. Rate of babies with neonatal birth injury, neonatal encephalopathy and post-delivery 
transfer to neonatal intensive care unit 
Given that maternity care covers different types of care over a long period of time (antenatal 
care, intrapartum care, postnatal care and neonatal care) it is not surprising that different 
initiatives for assessing quality have slightly different focus and thereby have slightly 
diverging proposals for exact indicators for assessment. However, in terms of intrapartum 
care, there is a relatively large consistency around the most relevant quality indicators, 
including mode of labour onset, mode of delivery and rates of maternal and neonatal 
complications. 
As described above, the use of PROMs to capture information on patients’ health and 
wellbeing has been widespread in many therapeutic areas. In maternity care, PROMs could 
be used to capture outcomes important to women with a holistic rather than strictly clinical 
assessment of their health throughout pregnancy, labour, and the postpartum period [47]. 
However, to date little work has been done in terms of systematic use of PROMs in maternity 
care even though initiatives are currently ongoing at international (through ICHOM [48]) and 
national levels (through the Pregnancy register). There is also increasing interest in 
measurement of Patient reported experience measures (PREMs). Women’s experience of 
childbirth has significant short-term and long-term effects on well-being and health, and has 
also been shown to impact future reproduction [49]. There is a variety of different scales 
available for assessment of PREMs in relation to childbirth care, but systematic collection of 
such data is limited [50].  
1.6.2 Analyses of case mix impact and variations in caesarean section rate 
The most frequently investigated aspect of childbirth care is the use of caesarean section 
(CS). Rates of CS has been increasing globally without obvious positive effect on health and 
with substantial variations between countries and between hospitals [51]. CS rate is a well-
established indicator of maternity care quality [46, 52, 53] and in light of the maternal and 
neonatal complications and higher resource use that are associated with CS [54-57], it is an 
important indicator to understand performance.  
Monitoring of CS rate at hospital level has often been performed using the Robson 
classification. The objective of the Robson classification is to provide a tool for clinical 
improvement, by allowing for comparisons between hospitals and increasing the 
  13 
understanding of contributors to CS rates [58]. However, the Robson classification does not 
fully account for differences in case mix between hospitals and the need for using risk-
adjusted CS rates in interhospital comparison has frequently been pointed out [46, 59, 60].  
There is an abundance of literature available regarding both the impact of case mix on the 
risk of CS, as well as estimates of case mix adjusted differences between hospitals. One of 
the first and most frequently cited studies is the one by Aron et al. [61] from 1998. They 
included a broad set of clinical predictors and found significant effects of many obstetrical 
conditions and complications during pregnancy on the risk of CS. They also demonstrated the 
importance of incorporating pre-existing comorbid conditions in risk adjustment. Their study 
also highlighted important unwarranted variation in CS rates and showed that ranking 
hospitals after unadjusted and adjusted CS rates gave different results. Another early study 
from the United States was performed by Glantz et al. [62], who found factors such as 
nonvertex presentation, previous CS, parity, and a number of different complications during 
pregnancy were found to be associated with higher risk of CS. In addition to these early 
studies, several additional investigations of case mix adjusted CS rates in the United States 
have been published [63-65]. 
Numerous studies have also been performed in a European setting. Paranjothy et al. [66] 
performed a study of 216 maternity units in England and Wales and estimated that 34% of the 
difference in CS rates across units was attributable to differences in case mix. In another UK 
study, Bragg et al. [67] studied case mix adjusted variations in CS rates between NHS trusts. 
They observed factors such breech position, placenta praevia or placental abruption, parity 
and previous CS to be strong predictors of CS and concluded that “…comparing unadjusted 
rates of caesarean section should be avoided”. An Italian study by Maso et al. [68] also 
reported strong effects of case mix factors such as maternal age, BMI, gestational age and 
parity on CS rate. Their analysis showed that risk stratifying based on the Robson 
classification provided a reasonably good adjustment but that the adjustment was improved 
by including additional maternal characteristics in the risk adjustment. Several studies of 
variations in CS rates have been performed in different Italian settings [60, 69, 70]. 
Elsewhere in Europe, variations in CS rates with case mix adjustment have been presented 
for Denmark [71], Finland [72], and Ireland [73] while data has also been reported for 
Australia [74]. 
1.6.3 Analyses of case mix impact and variations in other performance 
indicators 
As described above, CS rate is a universally accepted indicator of quality in maternity care. 
However, the extremely large dominance of CS as a birth care performance indicator is likely 
to a large extent driven by the relative ease with which it can be captured: It’s a widely 
available indicator which can be identified through diagnosis codes and procedure codes 
available in essentially any patient administrative data and there is no ambiguity around its 
definition. However, while it is linked to outcomes and resource use [54-57], it is formally 
only a measure of the care process and despite being by far the most studied quality indicator 
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in childbirth care, it is by no means the only relevant indicator. To adequately assess and 
improve performance in childbirth care, a broad spectrum of indicators of care process, 
resource use, health outcomes, and experiences of women giving birth are needed. As 
discussed in section 1.6.1, several different indicators of relevance for studying childbirth 
care performance have been proposed. A number of these have been investigated in the 
literature.  
In terms of health outcomes, a study from the United States investigated variations in both 
maternal adverse outcomes (postpartum haemorrhage, peripartum infection, perineal 
lacerations) and a composite measure of neonatal adverse outcomes [75]. That study 
observed age, BMI and obstetric history to be strong risk factors of virtually all adverse 
outcomes. The Royal College of Obstetricians and Gynaecologists in the UK has presented 
case mix adjusted data for obstetric anal sphincter injuries (OASIS) and emergency 
readmission [76]. Risk adjustment models for improved benchmarking have also been 
investigated for severe perineal tears in Australia [77]. Factors such as maternal age, 
nulliparity and higher birth weight were all found to be risk factors of severe perineal tears.  
Induction of labour has been proposed as quality indicator because it has an impact on care 
process and outcomes [52]. A study from the United States demonstrated large variations in 
labour induction rates and observed factors such as preeclampsia, oligohydramnios, 
polyhydramnios and post-term pregnancy to be risk factors for induction of labour [78].  
Length of hospital stay is an important indicator to understand resource use in relation to 
childbirth care. However, the impact of demographic and clinical risk factors on length of 
stay, and variations in length of stay between hospitals, has received limited attention in the 
literature. This could be due to a perception that length of stay is of lower clinical relevance 
compared to other indicators of care process and outcomes. Nevertheless, a Canadian study 
[79] demonstrated large interprovincial variation in length of stay, albeit with limited 
adjustment for case mix. A study from the United States identified significant variations in 
length of stay. That study thoroughly investigated the impact of case mix and found that most 
obstetric complications and pre-existing medical conditions were linked to a longer length of 
stay, demonstrating that adjustment for maternal characteristics are important for the 
relevance of such interhospital comparisons [79]. 
1.6.4 Performance measurement and improvement in childbirth care 
There are few documented examples in scientific literature of targeted improvement 
programmes in childbirth care involving performance monitoring. One example, however, is 
ProvenCare Perinatal, a programme intended to reduce unwarranted variation and increase 
adherence to evidence-based care, where timely data feedback is an integral component. 
Early evidence indicated positive results from the programme, including a large decrease in 
CS rate at one of two studied medical centres [80]. Another example from the United States is 
the use of a report-generating computer system at California Pacific Medical Center. 
Intensive feedback on CS rates and outcomes was provided to the medical and nursing staff 
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at one intervention hospital and was compared to a control hospital were the system was 
introduced at a later stage. The primary endpoint investigated was CS rate, where the system 
was observed to contribute to reductions in CS rates from 24-25% to 20-21% [81]. In 
Sweden, Region Östergötland is the region with the lowest current rate of CS (around 12%). 
They had a CS rate of almost 19% in 2006 [82]. The largest unit in that region obtained a 
sharp decrease in CS rate through a structured programme including continuous monitoring, 
organizational changes and training [83]. 
1.7 SVEUS  
Sveus is a Swedish national programme which is central to this thesis and therefore warrants 
a brief introduction. Sveus was initiated in 2013 by the Ministry of Health and Social Affairs 
to develop value-based governance tools for the healthcare system. The background to the 
initiative was an ambition to collaborate cross-regionally to face common challenges such as 
increasing costs and variations in results. Among reasons for the cross-regional collaboration 
were to enable better possibilities for benchmarking and comparisons, to have more data 
available for development of case mix adjustment algorithms, and to share development costs 
in the project. Seven regions participated in Sveus (Jämtland Härjedalen, Östergötland, 
Dalarna, Uppsala, Skåne, Stockholm and Västra Götaland) covering around two thirds of the 
Swedish population. Sveus took inspiration from the framework value-based health care, 
which is a framework for health care management that has gained attention both 
internationally and in Sweden [84]. Within this framework, value is defined as patient 
relevant health outcomes achieved in relation to the costs of achieving those outcomes. 
Among proposed solutions for achieving higher value are improved transparency and 
reimbursement for entire cycles of care [85]. Initially, both reimbursement and transparency 
were core parts of Sveus, but over time reimbursement was deemed of lower relevance for a 
national collaboration. Therefore, the main focus of Sveus has been on development of 
methodology and systems to enable advanced analytics and continuous monitoring of case 
mix adjusted health care performance, with instant feedback to providers.  
In 2016, a technical platform for continuous analysis and benchmarking of regions and 
hospitals was launched as part of Sveus. The platform is continuously fed with new data from 
administrative systems and quality registers and captures all health care contacts (primary 
care, outpatient specialized care and inpatient care) for around two thirds of the Swedish 
population. Both payers and providers have access to a web-based interface and can 
continuously monitor results in relation to resource, adjusted for differences in case mix.  
Sveus as a project ended 31 December 2017 and the collaboration has now transitioned into a 
continuous phase. Throughout the five years, a total of around 150 participants and 50 
different organizations were involved in Sveus. Childbirth care constituted one of eight initial 
patient groups in Sveus. A cross-professional expert group comprising representatives from 
professional organizations, payers, providers and quality registers were invited to participate 
in Sveus childbirth care, with the objective of designing a system for monitoring of childbirth 
care. A total of 17 meetings were held with the expert group from August 2013 through 2016. 
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As part of the work, the scope of the episode of care was defined and relevant indicators of 
health outcomes, care process, resource use, and patient characteristics were identified 
through a combination of previous literature, exploratory quantitative analysis, and expert 
opinion. 
As part of the development of logic and methods for monitoring of childbirth care, extensive 
data analysis of historical data was carried out based on a comprehensive research database 
including data from regional Patient Administrative Systems (PAS), the Medical Birth 
Register (MBR), the Pregnancy Quality Register, the Neonatal Quality Register and 
sociodemographic data from Statistics Sweden. 
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2 AIM 
The overall aim of this thesis is to analyse unwarranted variations in health care and to assess 
how such measurement of performance can enable quality improvement. The specific 
research questions are:  
1. What is the impact of patient characteristics on different indicators of birth care 
performance?  
2. How much does the rate of caesarean section vary between Swedish hospitals after 
adjustment for differences in case mix? 
3. How much do different indicators of health outcomes vary between Swedish hospitals 
after adjustment for patient characteristics and do hospitals that perform well on one 
indicator also perform well on others? 
4. What factors can facilitate or hinder the adoption of technology-supported quality 
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3 METHODS 
3.1 DATA AND STUDY POPULATION 
Study I-III were all based on the Sveus childbirth research database. While Study I was 
focused on investigating the impact of case mix factors on different indicators of performance 
in childbirth care, Study II and III aimed at investigating interhospital variations in rate of 
caesarean section (II) and in health outcomes (III). The quantitative analyses for these studies 
were all based on the same underlying dataset. The database used for Study I-III was based 
on regional and national databases from 2009 to 2012. Women giving birth during 2011 and 
2012 were identified using ICD-10 codes O80-O84 in PAS from the seven Swedish regions 
which participated in Sveus. For each woman, information on diagnoses and procedures in 
inpatient care and outpatient specialist care were extracted from PAS from two years before 
until 12 weeks after the date of admission for delivery. To capture maternal factors not 
available in PAS, such as parity, previous CS and BMI, as well as Apgar score for the 
newborn, information for these women was also extracted from MBR [86]. In addition, data 
from Statistics Sweden were used to capture information on maternal country of birth [87]. 
Extremely and very preterm deliveries (around 1% of all deliveries) and women who gave 
birth in a region different from the one they lived in at the time of delivery (around 3% of all 
deliveries) were excluded from analysis. A total of 140 296 deliveries during the study period 
were identified in PAS. For 99.6% of these a match in the MBR could be identified, resulting 
in 139 756 deliveries used for analysis. 
3.2 DEFINITIONS OF INDICATORS 
3.2.1 Baseline characteristics (case mix factors) 
Based on previous literature and clinical expertise, a number of baseline characteristics 
deemed relevant for case mix adjustment were identified. The objective was to determine the 
impact of patient characteristics outside of the birth clinic’s control on indicators of care 
process, resource use and health outcomes. Hence, only factors that were deemed not to be 
the result of the delivery ward’s care process were included as case mix factors. 
Table 1 Patient characteristics used for case mix adjustment 
Variable Data source Criteria 
Sociodemographic factors 
  
Age PAS Age at admission for delivery 
Born outside EU Statistics Sweden 
 
Obstetrical characteristics  
  
First birth MBR 
 
Previous caesarean section MBR/PAS Information in MBR or presence of codes O342 
or O757 in PAS 
Non-cephalic presentation PAS O321, O322, O641, O644, O801, O830, O831 





PAS O601C eller O603C 
BMI MBR BMI at first prenatal appointment 
Complications during pregnancy  
  
Cervical insufficiency PAS O343 
Infection of amniotic sac PAS O411 
Pre-eclampsia PAS O14 
Post-term pregnancy PAS O489 
Gestational diabetes PAS O244 
Polyhydramnios PAS O409 
Oligohydramnios PAS O410 
Placenta praevia PAS O44 
Premature rupture of 
membranes 
PAS O42 
Bleeding during pregnancy PAS O46 
Placental abruption PAS O45 
Herpes PAS N77 
Intrauterine growth restriction PAS O365 
Hepatosis PAS O266 
Comorbidities  
  
Blood diseases PAS D500, D501, D508, D53, D55, D57, D58, D59, 
D6, D7, D8 
Substance abuse PAS Z714, Z721, Z715, Z722, F10-F19 
Endocrine and metabolic 
diseases 
PAS E00-E07, E1-E5, E60, E61, E63, E64, E67, E68, E8 
Gynaecological diseases PAS N882, N883, D25, N99, N31-N37, Q51 
Heart and vessel diseases PAS I80, I81, I82, I85, I86, I87, I0-I7, I9 
Infectious diseases PAS A5-A9, B1, B2 
Liver diseases PAS K70-K77 
Lung diseases PAS J40-J47 
Neurological diseases PAS G621, G50-G55, G57, G58, G59, G0-G4, G7, G8, 
G9 
Renal diseases PAS N0, N1, N2, I120, I131, N250, Z490, Z491, Z492, 
Z940, Z992, N18, N19 
Mental disorders PAS F204, F302, F312-F315, F341, F412, F432, F20, 
F22-F25, F28, F29, F32, F33 
Musculoskeletal diseases PAS M05, M06, M3, M6 
Bowel diseases PAS K50, K51, K52, K55-K59, K6 
Tumour diseases PAS C1-C9 
 
3.2.2 Performance indicators 
To understand performance several different indicators were used in Study I-III. The 
objective was to adequately describe key measures of health outcomes, the resource use and 
care process. The performance indicators were selected based on a combination of review of 
previous research and clinical expertise. The indicators are listed below, along with data 
source and definition. 
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Indicators of resource use and care process 
• Length of hospital stay (PAS; calculated as date of discharge – date of admission)  
• CS (PAS; ICD-10 O82, O84.2 or procedure codes MCA00,10,20,30,33,96)  
• Induction of labour (PAS; ICD-10 O61 or procedure codes MAC10, DM002, DT027, 
DT036) 
Indicators of health outcomes 
• Perineal tears of degree 3 and 4 (PAS; ICD-10 O70.2-3) in vaginal deliveries  
• Haemorrhage>1000 ml (PAS; ICD-10 O67.8, O72) up to two weeks post-partum  
• Post-partum infections up to 12 weeks following admission for delivery, including  
o cystitis (PAS; ICD-10 N30, O86.2) 
o endometritis (PAS; ICD-10 N71, O85.9)  
o other delivery-related infections (PAS; ICD-10 O86.0,3,4,8, Y95.9).  
• Apgar<4 at 5 minutes (MBR) 
3.3 STATISTICAL ANALYSIS 
In Study I, regression analysis was employed to assess the impact of case mix factors on the 
indicators of interest. Logistic regression was performed for all dichotomous outcomes, while 
the length of stay in days was analysed using ordinary least squares (OLS) regression. The 
full set of case mix factors was used in all regression models. To evaluate model fit for the 
logistic regression models, the c-statistic, calculated as the area under the receiver operating 
characteristic (ROC) curve, was used. Model fit for the regression model for length of stay 
was evaluated using R-square. 
In Study II and III, each hospital’s deviation from the mean rate of each studied indicator was 
estimated using a fixed effects logistic regression analysis with a dummy variable for each 
hospital. Effect coding was used for the hospital dummy variables so that each hospital’s 
estimate used the overall rate (the population mean) as a reference value. To study potential 
correlations between different indicators, the Spearman correlation coefficient was used. 
All statistical analysis was carried out using STATA 13.1 (STATA Corporation, College 
Station, TX). 
3.4 METHODS USED IN STUDY IV 
Study IV was a qualitative study, conducted at the obstetric unit at a Swedish university 
hospital. The unit was selected because of its unique and innovative technology-supported QI 
programme. The unit used an analytics platform to support QI through continuous 
performance measurement and data feedback. The platform included data on observed and 
predicted (based on case mix) levels of indicators from the Sveus platform and additional 
data from local medical records to enable continuous tracking of local performance on a 
broad spectrum of indicators. Various dashboards for performance measurement were made 
available to the unit through web-interfaces and were all updated weekly to ensure timely 
 22 
feedback. The rationale for choosing a qualitative design was to provide an in-depth 
understanding of how managers and staff at the unit perceived the adoption of technology for 
supporting QI. 
Data was collected through three semi-structured focus group interviews conducted with 
informants (n=16) during September and October 2018. The focus group interview was used 
to enable the informants to collectively discuss their experiences concerning the topic and to 
stimulate reflections that might not have appeared in an individual interview [88]. The 
interviews were led by one facilitator and two researchers participated as observers. 
Interviews lasted 75 to 90 minutes and were audio-recorded and transcribed verbatim. The 
interview guide used is presented in the Appendix. 
Purposive sampling was used to include 1) managers (n=4; 2 midwives, 2 physicians), 2) 
staff that were actively engaged in the QI programme (n=6; 2 midwives, 2 physicians, 2 
assistant nurses) and 3) staff that were not actively involved in the QI programme (n=6; 2 
midwives, 2 physicians, 2 assistant nurses). The sampling and the division of participants into 
separate groups were chosen to capture the dissemination of the programme, the perception 
of it at different organizational levels, and to avoid power imbalance that could hinder the 
participants’ ability to speak freely [88].  
Directed content analysis was used, which is a deductive methodology where existing theory 
or prior research about a phenomenon is used [89]. In this study the data collection and 
analysis were guided by the Nonadoption, Abandonment, Scale-up, Spread, and 
Sustainability (NASSS) framework [41]. The analysis was performed in five different steps: 
First, the entire interviews were read by two researchers to get an understanding of the 
material. Second, these two researchers independently condensed the first transcribed 
interview into coding units (reducing the number of words while staying close to the text) and 
compared results to ensure consistency in level of condensation. Then the two researchers 
each condensed one of interviews two and three. Third, three researchers sorted the coding 
units into the NASSS domains and subcategories were created. Fourth, the content of each of 
the seven domains was discussed and synthesized descriptions of the empirical data were 
developed by the research team. Fifth, based on these descriptions, each member of the 
research team participated in categorising each domain into “simple”, “complicated”, or 
“complex” in a process where each researcher presented their view, and discrepancies were 
discussed and resolved. 
The Consolidated Criteria for Reporting Qualitative Research (COREQ), a 32-item checklist 
for interviews and focus groups, was used to ensure adequate reporting of the methodology 
and analysis [90]. 
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3.5 ETHICAL CONSIDERATIONS 
Study I-III were all based on register-data. For these a study protocol summarizing 
background, data sources, variables, and proposed methods was submitted to and approved 
by a regional ethical committee. Subsequently, each data holder approved use of data for the 
study. In the scientific communication only aggregated data, which was not possible to link to 
any specific individual, was presented. The Stockholm Regional Ethical Review Board 
approved the study protocol (Dnr 2013/447-31/5, 2013/1686-32) for Study I-III. Study IV 
was a qualitative study based on focus group discussions. Each respondent signed an 
informed consent form prior to the interview. The Stockholm Regional Ethical Review Board 
approved the study protocol (Dnr 2018/1644-31/5).  
This research has been carried out as part of my employment in Ivbar, which is a company 
that develops analytics products for the health care sector. While this constitutes a potential 
conflict of interest, I also believe that combining research with work in the area of 
performance measurement has helped me gain a better understanding of the practical aspects 
of performance measurement and QI. Getting hands-on experience of how both payers and 
providers work with data day-to-day and make decisions, has helped me understand the 
possible applications of the sometimes more theoretical research activities. 
Study I-III are relatively general in nature and are not directly related to any Ivbar product. 
Study IV, however, studied a technology-supported QI programme where a technical solution 
developed by Ivbar was used. My personal involvement in that particular QI programme was 
limited, but I did meet the clinic at several occasions early in the process to discuss the scope 
and design of the work. To ensure that my personal involvement in the work and my role at 
Ivbar did not influence the discussions and interactions among the interviewees, I did not 
participate in any of the interviews.   
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4 RESULTS 
4.1 DESCRIPTIVE STATISTICS (STUDY I-III) 
Table 2 presents the number of deliveries per hospital in the seven included regions.  
Table 2 Regions and hospitals included in the analysis 





126 147 Östersund Hospital  RJH ÖSD 2276 
Östergötland 433 462 
University Hospital Linköping and 
Vrinnevi Hospital Norrköping 
RÖ LN 8956 
Dalarna 276 379 Falun Hospital LTD FL 4728 
Uppsala 341 465 Akademiska University Hospital LUL AS 7010 
Skåne 1 262 068 
Helsingborg Hospital RS HBG 5652 
Central Hospital Kristianstad RS CSK 3258 
Skåne University Hospital Lund RS SUSL 6321 
Skåne University Hospital Malmö RS SUSM 8757 
Ystad Hospital RS YST 2171 
Stockholm  2 123 337 
BB Stockholm SLL BBSth 7325 
Danderyd Hospital SLL DS 12 148 
Karolinska University Hospital Huddinge SLL K Hudd 8370 
Karolinska University Hospital Solna SLL K Solna 7475 
Södertälje Hospital SLL STS 2880 
Stockholm South General Hospital SLL SÖS 13 616 
Västra Götaland 1 598 700 
Södra Älvsborg Hospital VGR SÄS 4810 
NU Hospital group VGR NU 5345 
Skaraborg Hospital VGR SkaS 3897 
Sahlgrenska University Hospital Mölndal VGR SU/M 7036 
Sahlgrenska University Hospital Östra VGR SU/Ö 10 832 
*2012 Population numbers from Statistics Sweden [91] 
Table 3 below presents descriptive statistics for the patient population used for analysis in 
Study I-III. Mean age at admission for delivery was 30.7 years, while 21% of women were 
born outside the EU. Slightly below half of women were nulliparous and 10% had a previous 
caesarean section. Mean BMI at time of first visit to maternity care was 24.5 kg/m2. This case 
mix factor was missing for 5% of the population. The most common complicating factor 
during pregnancy was post-term pregnancy, followed by intrauterine growth restriction and 
pre-eclampsia. 
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In terms of care process, the overall rate of CS and induction of labour was 17% and 15%, 
respectively, while mean length of stay was 2.6 days. Among vaginal deliveries, 3.6% 
resulted in a degree 3 or 4 perineal tear. Haemorrhage over 1000 ml occurred in 7.8% of 
deliveries. The rate of post-partum infection was 4.2%. Among post-partum infections, 
endometritis was most common (2.2%), followed by other infections and cystitis (1.5% and 
0.7%, respectively). An Apgar score below 4 at 5 minutes was observed in 0.32% of 
deliveries. 













Age (mean;sd) 30.7;5.2 139756 
Born outside EU 21.3% 139756 
Obstetrical factors BMI (mean;sd) 24.5;4.7 132917 
First birth 44.9% 139701 
Previous caesarean section 10.0% 139756 
Other position than head first 3.5% 139756 
Multiple birth 1.3% 139756 
Premature 4.2% 139756 
Complications 
during pregnancy 
Cervical insufficiency 0.3% 139756 
Infection of amniotic sac 0.2% 139756 
Pre-eclampsia 3.4% 139756 
Post-term pregnancy 5.0% 139756 
Gestational diabetes 2.0% 139756 
Polyhydramnios 0.5% 139756 
Oligohydramnios 1.9% 139756 
Placenta praevia 0.7% 139756 
Premature rupture of membranes 1.9% 139756 
Bleeding during pregnancy 3.0% 139756 
Herpes 0.6% 139756 
Intrauterine growth restriction 3.7% 139756 
Hepatosis 0.8% 139756 
Placental abruption 0.3% 139756 
Comorbidities Number of comorbidities (mean;sd) 0.23;0.52 139756 
Care process Care process CS 16.9% 139756 
Labour induction 15.0% 139756 
Resource use Resource use Length of stay (mean;sd) 2.60;1.98 139756 
Health outcomes Maternal outcomes Perineal tear grade 3 or 4 3.6% 114638 
Haemorrhage>1000 ml 7.8% 137940 
Postpartum infection 4.2% 126387 
Neonatal outcomes Apgar<4 at 5 minutes 0.32% 139198 
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4.2 IMPACT OF CASE MIX FACTORS ON IMPORTANT PERFORMANCE 
INDICATORS (STUDY I) 
Six different indicators of performance were assessed. Measures of health outcomes included 
perineal tears of degree 3 and 4 in vaginal deliveries, haemorrhage>1000 ml, as well as post-
partum infections up to 12 weeks following admission for delivery. The two care process 
indicators analysed were CS and induction of labour, while length of hospital stay was used 
as resource use indicator.  
A large number of baseline characteristics deemed relevant for predicting outcomes and 
resource use were identified based on previous literature and based on clinical expertise (see 
exact list and definitions in Table 1). 
The importance of different case mix factors varied across the six performance indicators. 
Higher maternal age was a consistent risk factor and was observed to increase both length of 
stay and rates of labour induction, CS, perineal tears, and haemorrhage. Being born outside of 
the EU was also a risk factor for labour induction and CS, as well as longer length of stay and 
adverse obstetric events. Obstetrical characteristics such as nulliparity and previous CS were 
strongly associated with higher risk of CS, longer hospital stay and with higher risk of severe 
perineal tears, haemorrhage and infections. Multiple birth had a strong impact on risk of 
haemorrhage. However, premature delivery was associated with significantly lower risk of 
both perineal tears and haemorrhage. 
 
Figure 4 Receiver operating characteristic curves of the five models with dichotomous outcomes 
Generally, the impact of case mix was largest for indicators of care process. Both for 
caesarean section, labour induction and length of stay, many of the case mix factors showed 
statistically significant effects. The predictive ability was lower for health outcomes. Figure 4 
illustrates the ability of the models to predict which patients received CS, labour induction or 
experienced the different adverse outcomes. The predictive ability was highest for CS 
(c-statistic 0.84), followed by labour induction (c-statistic 0.78), indicating that the model 
could reasonably well predict these indicators. For perineal tears the c-statistic was 0.72, 
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while the predictive ability was lower for haemorrhage and post-partum infections 
(c-statistics of 0.61 and 0.63, respectively), indicating that the maternal characteristics 
included had a smaller impact on these two indicators. For length of stay, the regression 
model was able to explain 28% of the variation. 
4.3 CASE MIX ADJUSTED VARIATIONS IN CAESAREAN SECTION RATE 
(STUDY II) 
The second study was based on same research database that was used for Study I. The 23 
different sociodemographic and clinical characteristics investigated in Study I were used for 
case mix adjustment. Analyses were performed for the entire study population as well as for 
two different subgroups: nulliparous, cephalic, full-term, singletons (Robson groups 1 and 2) 
and multiparous, cephalic, full-term, singletons, with no previous CS (Robson groups 3 and 
4). The potential relationship between CS rate and neonatal outcome was investigated using 
Apgar score<4 at 5 minutes.  
The mean CS rate was 16.9% and as Figure 5 shows the observed hospital-level CS rate 
varied from 12.1% to 22.6%. Differences in case mix caused large variations in expected rate 
of CS between hospitals, from 13.7% at Skaraborg hospital to 19.9% at Karolinska university 
hospital Solna. Among the 20 hospitals, 7 had significantly lower case mix adjusted CS rate 
compared to the population mean, while 6 had significantly higher rate and 7 hospitals did 
not have a statistically significant deviation from the population mean.  
 
Figure 5 Observed caesarean section rate, expected caesarean section rate and case mix adjusted deviation from mean 
caesarean section rate (all deliveries). (Note: The odds ratio (OR) represents each hospital’s deviation from the weighted 
average of all hospitals) 
In general, the patterns were relatively similar in the two subgroups investigated. Hence, 
hospitals with a higher than expected CS rate in one subgroup tended also to have higher than 
expected CS rate in the other subgroup (correlation coefficient 0.44; p=0.052).  
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If all hospitals had performed as many CS as the 20% of hospitals with lowest case mix 
adjusted rate, it would have caused a reduction of 2200 CS annually in the regions included in 
the study, which would have entailed cost savings of around €7M annually during the initial 
admission for delivery alone. 
Figure 7 shows the relationship between case mix adjusted CS rate on one hand and case mix 
adjusted rate of low Apgar score on the other. As the figure shows, there were variations 
between hospitals both in the rate of CS and the proportion newborn with low Apgar, but 
there was no evidence of relationship between the two (correlation coefficient 0.020; p=0.93). 
  
Figure 6 Association on hospital level between CS rate and proportion newborn with Apgar<4 at 5 minutes, both adjusted 
for case mix (Note: The log OR represents each hospital’s deviation from the weighted average of all hospitals. Each bubble 
represents a hospital. The area of the bubble corresponds to the number of deliveries during the time period.) 
 
4.4 INTERHOSPITAL VARIATIONS IN HEALTH OUTCOMES IN CHILDBIRTH 
CARE (STUDY III) 
This study used the same research database as Study I and II and employed the same case 
mix factors and statistical methodology as Study II to study variations in performance. Four 
indicators of health outcomes, all of which have been deemed relevant indicators of quality of 
maternity care services [45, 46], were selected for analysis. 
As presented in Figure 7, statistically significant interhospital variations were observed for all 
studied indicators. There was no hospital which had a statistically significant higher or lower 
rate on all four outcomes indicators. The top 5 hospitals for each indicator were compared to 
the remaining 16 hospitals. If these 16 hospitals had performed as the case mix adjusted 
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average of the 5 hospitals that performed best for each indicator, a total of 890 OASIS 
(-23%), 2700 haemorrhages (-26%), 1500 infections (-30%) and 180 newborns with Apgar<4 
at 5 minutes (-42%) would have been avoided over the two years studied.  
There was a slight positive correlation between performances across different indicators of 
health outcomes, even though this was not statistically significant in most cases. 
 
Figure 7 Case mix adjusted deviation from population mean for each health outcome indicator 
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4.5 HOW TECHNOLOGY CAN SUPPORT QUALITY IMPROVEMENT IN BIRTH 
CARE (STUDY IV) 
In Study IV the NASSS framework was used to identify factors that can facilitate or hinder 
the adoption of technology-supported QI, based on interviews with managers and staff in an 
obstetric unit.  
In terms of the domain Condition, the analytics platform was capable to handle the challenge 
of measuring quality in obstetric care at the department, which ranged from treating low-risk 
patients in normal labour to high-risk patients with comorbidities and complications.  
As for the Technology domain, several factors facilitated the adoption of the platform. The 
interviewees described that data was provided in a timely manner and that case mix 
adjustment made data more relevant compared to unadjusted data, both of which contributed 
to its relevance for QI. The presentation of the data and statistics in the dashboards was 
deemed to be easy to understand and user-friendly. Moreover, interviewees reported that the 
relationship with the supplier was such that it was possible to customize the analytics 
platform to the local needs and conditions, particularly in terms of communicating with the 
hospital IT department and adapting to the local data. One barrier to the adoption was that 
staff groups described the need for guidance and support to identify, select, extract, and 
present relevant data. Prior understanding of statistics was also perceived to be helpful to 
fully understand the presented data.  
Related to the Value Proposition, the platform was perceived as desirable which supported 
its adoption. Even before the launch of the technology-supported programme, data was 
perceived as an important tool for QI. However, historically the data entered into medical 
records had been difficult to access and use and was not sufficiently up-to-date to support QI 
at the unit.  
As for the Adopter system, managers and staff involved in QI teams were the main users of 
the platform and its adoption did not imply substantial changes to individual roles and 
identities which supported the adoption. Managers and staff involved in QI teams used the 
data to identify performance deviations and needs for improvement grounded in valid 
information. In addition to using the platform, other data sources were used as a complement. 
For example, surveys, focus groups, and individual interviews with patients were used to gain 
the patient perspective on quality of care. Based on data from the platform and informed by 
available evidence and experience from other settings, changes were made to clinical 
protocols. The data available in the platform could be used to support quick feedback on 
improvement changes and observed results. A barrier to the adoption of the technology, was 
that interviewees identified some risks associated with the use of performance data for QI. 
For example, staff in involved in QI teams described a concern that improvement efforts 
would solely focus on areas that could be measured, i.e. areas that could not be measured 
quantitatively were at risk of not being prioritized. Some challenges related to spread of the 
platform were also raised. The ambition was that all employees could have access and use the 
  31 
analytics platform. In practice, however, staff not directly involved in QI teams stated that 
they had limited or no knowledge or experience of working with the platform. 
In terms of Organization, several factors supported the adoption of the platform. The 
department reported that they had a history of working with QI, for instance with lean, and 
several QI initiatives were already ongoing before the platform was introduced. Moreover, 
the QI teams were multidisciplinary, including physicians, midwives, and assistant nurses. 
This created unity around both the conclusions and the proposed changes among multiple 
professional groups. The head of unit had an important role in facilitating the adoption of the 
platform, by engaging staff through showing the possibilities that the platform offered. This 
bottom-up strategy was believed to ensure sustainable adoption of the platform and decrease 
risk of abandonment. Managers used data to motivate staff to QI and the staff expressed that 
they experienced the visualization of completed and ongoing QI efforts as a motivating factor 
to continue improving. The increased focus on measurement and benchmarking led to an 
increased and shared understanding of the importance of data reliability. One hinder in the 
adoption process was that certain variables were found to be of insufficient quality to be 
useful for performance measurement. Thus, several efforts were made to improve routines 
regarding data recording. 
The adoption was facilitated by the fact that the Wider system was characterized by a wide-
spread societal and political debate on the need to improve birth care. Moreover, the hospital 
implemented a general initiative to adopt value-based health care (VBHC) as an improvement 
strategy. Managers reported that the unit’s initiative linked to the hospital-wide initiative and 
this gave the unit some support in the improvement effort. 
Because the data was collected around one year after implementation of the technology, the 
study focused mainly on early adoption of the technology and limited information was gained 
regarding Embedding and adaptation over time. During the early period, the results show 
that the platform supplier and its adopters worked to co-develop the platform in a way that 
was suitable for local data availability and needs. Moreover, the head of unit had a clear 
strategy for securing motivation of staff and mitigating risk of abandonment. However, the 
results do allow for assessing the ability of the department to embed and adapt the technology 





This thesis presents approaches for a thorough measurement of health care performance, 
using routinely collected register-based data. It demonstrates the importance of case mix 
adjustment and reveals large interhospital variations in performance after adjustment for case 
mix. Finally, it presents facilitators and barriers for adoption of technology-supported quality 
improvement in a hospital department.  
5.1 INTERPRETATION OF FINDINGS 
The importance of case mix adjustment is well established in the literature and this thesis 
confirms that adjustment for case mix is a prerequisite for valid assessment of performance. 
The analysis of CS rates showed that the ranking of hospitals differed significantly after case 
mix adjustment compared to before case mix adjustment, which highlights the importance of 
accounting for differences in patient characteristics. This thesis also shows that adjustment 
for case mix is motivational for health care professionals. Interviewees from the department 
working with data for QI stated that they had previously rationalized poor results by focusing 
on characteristic of their patient population rather than on the potential for clinical 
improvement. 
In the current era of “big data”, there are unprecedented opportunities for development and 
continuous refinement of models for adequate case mix adjustment. However, the choice of 
factors to use for case mix adjustment is not straight-forward. As the name reveals, the 
objective is to adjust for available information about the treated “cases” (i.e. patients). In this 
thesis, 23 different baseline characteristics have been used, which together give a thorough 
understanding of risk factors associated with performance indicators such as CS, length of 
stay, and adverse obstetric outcomes. Nevertheless, it is likely possible to identify additional 
factors that have an impact on performance indicators. Case mix adjustment can never be said 
to be perfect or complete.  
Given that the objective is to use the adjustment to reveal differences in performance between 
birth clinics, only factors outside of the clinics’ control should be adjusted for. The unit of 
comparison in this thesis is birth clinics and the patients’ clinical status at admission for 
delivery has been regarded as factors outside of the clinics’ control. However, it could be 
debated if all the factors used for case mix adjustment are outside of the clinics’ control. For 
example, both pre-term (delivery before week 36+6 days) and post-term birth (delivery after 
week 42+0 days) have been adjusted for in the analyses. However, one could argue that birth 
clinics’ management of labour and the choice of when to induce labour does impact if the 
woman ends up having these “risk factors” or not. Both pre-term and post-term delivery are 
very frequently used for case mix adjustment in birth care and have been included because 
they are largely driven by factors outside of the clinics’ control, but they serve as examples of 
the potentially difficult choice in the selection of what factors to adjust for. There are also 
factors that are very clearly within the control of the providers that have been used for case 
mix adjustment in previous literature. As an example, Leung et al. analysed case mix adjusted 
  33 
variations in length of stay and included factors such as hospital size and mode of delivery in 
the model [92]. While it may be interesting to analyse whether hospital size and mode of 
delivery impact length of stay, they are factors that are driven by care organization more than 
actual patient characteristics and are consequently not an adequate reflection of case mix.  
This thesis also underlines the importance of using a broad set of indicators for measurement 
of performance. As discussed, prior literature has focused almost exclusively on CS rate. 
While this is a highly relevant indicator it clearly does not adequately capture the 
performance of a birth clinic. A comprehensive understanding of performance requires 
information about which patients are treated, what care process they go through, which 
resources are consumed, and what outcomes are achieved. This type of information cannot be 
condensed into one or a couple of different performance indicators. Instead, to assess the 
ability of a hospital to deliver good health outcomes at a reasonable cost, a wide range of 
indicators is necessary. This thesis shows that different hospitals performed well on different 
indicators and all hospitals in this study had room for improvement on one or several 
indicators, which shows the importance of measuring an array of different indicators to 
understand where there is potential for improvement. As study II showed, there was no 
apparent link between CS rate and proportion of newborn with low Apgar score. When 
comparing findings from study II and study III, a tendency may be observed that hospitals 
with a higher rate of CS had a higher rate of post-partum infection and haemorrhage. This is 
logical given that surgery is associated with a risk of infection and bleeding. However, there 
was a large variation in both these and other outcomes that did not strictly follow the 
variation in CS rate, which shows that CS rate alone is not an indicator that adequately 
captures performance.  
It is worth pointing out that there is no gold standard method for deriving the possible 
potential for improvement based on the performance distribution of the units investigated.  
Performing better than average on a specific indicator does not necessarily mean that the 
performance is good or that the result is satisfactory. However, to use the hospital with the 
best value for each specific indicator may also not represent a reasonable benchmark. Firstly, 
due to natural fluctuations and a certain degree of random variation over time, the hospital 
with the best performance on a specific indicator could be regarded as an outlier. Such 
random variations present a particularly important problem when the number of events of 
interest is low, due to short time interval for analysis, low number of observations per unit, or 
rarity of the event of interest. Secondly, given the well-known issue of differences in coding 
between providers there is also a possibility that deviations in coding practice at some clinics 
influence the results. To reduce the impact of these issues, the performance of the top 20 per 
cent was used as the benchmark in analyses of improvement potential. An alternative 
approach to deriving the benchmark from the distribution of current performance is to decide 
on a fixed target level that represents good performance, e.g. based on guidelines or expert 
consensus. 
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In addition to observed differences between hospitals within regions, certain significant 
differences can also be observed between regions. For example, the regional CS rate varied 
between 11.6% in Region Östergötland and 21.6% in Stockholm in 2014 [93]. This suggests 
that there are regional differences in ways to organize and provide care that impacts 
performance. These regional differences are most likely more accentuated when crossing 
country borders. Given differences in care practice and culture between countries, 
international benchmarking should therefore present additional opportunities to understand 
potential for improvement. There is an abundance of literature around global rates of CS 
which show that Sweden has a low CS rate in an international perspective [94]. There are 
scarce international data around other birth care performance indicators investigated in this 
thesis. However, as part of the Euro-Peristat project, a study investigated rates of severe 
perineal tears in 20 European countries. This study found Sweden to be amongst countries 
with highest rates of perineal tears but also concluded that there are likely to be significant 
variations between countries in the assessment and reporting of severe perineal tears [95]. 
It is worth emphasizing that not all variation between hospitals, regions and countries is bad. 
As discussed in the Introduction section, the term “unwarranted variation” is used to describe 
variations that are not explained by differences in patient characteristics or patient 
preferences [9]. The objective of the extensive case mix adjustment performed in this thesis is 
to remove the effect of differences in patient characteristics on observed variations. However, 
the impact of possible differences in patient preferences is more difficult to ascertain. This is 
not an issue for indicators of health outcomes and experience measures, where all patients can 
safely be assumed to prefer better outcomes and experiences of health care. Nevertheless, it is 
possible that women at different hospitals and regions have diverging preferences in terms of 
delivering through caesarean section as opposed to vaginal delivery. Also variations in 
process and resource use indicators such as labour induction and length of stay may be 
impacted by patient preferences. However, the preferences of patients in relation to treatment 
decisions are obviously impacted by the information received from the health care system so 
patient preferences should not be regarded as a completely external factor that is cannot be 
impacted by health care providers. Innovation, which is by definition deviation from the 
norm, is another potential source of variation which should not be regarded as negative [96]. 
However, this type of variation should be seen during relatively limited time period when 
early adopters introduce new technologies or routines and therefore differ from the norm. If 
the health care system manages to spread effective innovations and diffuse best practice, 
these differences should disappear over time. This underlines the need for systematically 
measuring performance continuously to enable quick feedback to providers regarding the 
impact of changes to clinical practise. 
In order to use performance measurement for motivating health care professionals and enable 
learning and improvement, these professionals need to be involved in the selection of 
indicators and take ownership over them [18, 97]. One dimension of complexity in health 
care is the multitude of different professionals involved in care delivery, who in some cases 
have diverging views on what constitutes quality of care [98]. This thesis shows that access to 
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performance data with a variety of different indicators combined with multi-professional 
teams engaging in QI may bridge such differences and facilitate collaboration by creating a 
common view of current performance and a unity around the targets set. Moreover, while 
timely feedback of relevant data can support QI, it will obviously not by itself improve health 
care. Because “healthcare will not realise its full potential unless change making becomes an 
intrinsic part of everyone’s job, every day, in all parts of the system” [27], effective ways to 
engage and motivate those who should perform the improvement efforts continuously are 
required. This thesis finds that leadership to motivate staff and to create a culture of striving 
towards improving care processes is a fundamental component of continuous improvement.  
The complexity of introducing technology in health care implies that organizations need to be 
resilient and determined when introducing new innovations and it is important not to expect 
that a technology-supported programme will be perfect immediately [39]. Instead, a 
collaborative approach between the supplier and the organization, and an openness for 
adaptations to the local context is required. An organization using technology for feedback of 
performance data needs to take measures to integrate this into the local context and be open 
for gradual improvements over time. This includes both actual improvements of the 
technology itself and the data used, but also improvements in how the technology is being 
adopted and used in the daily work. 
5.2 STRENGTHS AND LIMITATIONS 
An important strength of the quantitative analyses in this thesis is that they are based on data 
covering around two thirds of all deliveries in Sweden during the time period investigated. 
Almost 140 000 deliveries were included in the analyses, which is a large sample of patients 
to robustly analyse the relationship between different case mix factors and performance 
indicators, and to estimate the amount of unwarranted interhospital variation. Moreover, 
Sweden’s long history of systematic data collection using personal identification numbers for 
record-linkage across different data sources provides excellent opportunities for register-
based studies using routinely collected data. In this thesis data from Patient Administrative 
Systems, the Medical Birth Register, and sociodemographic data from Statistics Sweden 
allowed for a comprehensive analysis of patient characteristics, health outcomes, care process 
and resource use in Swedish birth care.  
One obvious and fundamental challenge to measurement of performance is its dependency on 
valid data. The main limitation of the analyses of unwarranted variation in this thesis is the 
possibility of differences in coding between regions and hospitals. These differences may be 
due to differences in care process, screening practices, or clinical criteria for certain 
conditions, but can also simply be due to differences in the reporting of diagnosis and 
procedure codes into medical charts and into the administrative data. The research database 
included both administrative data and data from MBR, which is based on information from 
medical records. For some variables, information was available in both sources which 
enabled validation of the data. Performance indicators such as mode of delivery, labour 
induction and severe perineal tears were available in both sources of data. For these variables 
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the coding quality of diagnosis and procedure codes in administrative data was very high and 
in large agreement with the data in the MBR. One example of a problematic variable is 
gestational diabetes, where the large observed differences in the frequency of the diagnosis is 
likely to a large extent driven by differences in screening regimes [99]. The magnitude of 
differences in coding practices is difficult to ascertain. In study II, the provider with the 
highest and lowest observed value for each case mix factor was presented and the large 
differences between the two indicates variability beyond what can be explained by underlying 
patient population. Given the limited use and feedback of the data that is currently being 
reported by health care personnel, it is not surprising that the data quality is not perfect. 
Increasing use of reported data and transparency between hospitals and regions around the 
frequency of different conditions would likely be a strong driver for harmonization of the 
assessment and reporting of different conditions relevant for studying performance. One of 
the findings of study IV was that the unit working with technology-supported QI identified 
variables with insufficient quality and implemented new routines to standardize reporting of 
information in order to increase data quality. 
One limitation is the absence of any PROMs in the assessment of performance. The 
collection of PROMs for measurement of outcomes of care has historically been limited but 
is becoming increasingly used. In Sweden, systematic collection of PROMs and PREMs has 
recently been initiated through the Pregnancy register which will give excellent future 
possibilities for studying variations in the experiences and patient-reported outcomes of 
women giving birth in Sweden. However, no such data was available during the time period 
investigated in this thesis. Consequently, the assessment of maternal health outcomes was 
restricted to those identified in administrative data. In terms of neonatal outcomes, the 
analysis was restricted to the recorded Apgar score for the newborn. In the research database 
there was information on all diagnoses before and after delivery for the women but there was 
no information available on diagnoses for their newborns in neonatal and paediatric care. 
This limits the possibilities of drawing conclusions about actual long-term outcomes for the 
newborn. 
In addition to providing detailed analyses of performance and demonstrating unwarranted 
variations between birth clinics, a strength of this thesis is that it also includes the perspective 
of how performance measurement can be used in clinical practice to support improvement 
efforts. There is wide-spread belief that technology has the potential to support QI by 
providing timely and adequate feedback of performance data. While previous research has 
investigated methodological considerations related to performance measurement there is 
limited information in the literature about the hinders for engaging in data-driven QI 
supported by technology. In addition, there is limited knowledge about what is needed at the 
clinical level in terms of organization and adoption to really make use of performance 
measurement in the clinical improvement work. By conducting group interviews in a hospital 
department that has worked intensively with technology-supported QI, success factors and 
barriers have been better understood.  
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A strength of the qualitative study was the separate group interviews with different levels of 
staff. Both managers, staff involved in QI teams, and staff not involved in QI teams were 
included and were interviewed separately. The purpose with this approach was to reduce risk 
for power imbalances which could have hindered the interviewees to speak freely. It also 
allowed for a better understanding of adoption and spread throughout the organization and 
not only among managers and staff involved in QI. One methodological limitation is the fact 
that participants in the group interviews were recruited by the head of unit, who led the QI-
programme. It is possible that this led to certain selection bias, for example if staff who were 
more positive towards QI or new ways of working were recruited to a larger extent. The 
reason that the head of unit was responsible for recruitment was that she had the best 
understanding of who belonged to which group and she also had an overview of the staff’s 
schedule and was able to plan attendance in interviews. We deemed it to be difficult to recruit 
in another way but do acknowledge that this approach might have influenced selection of 
respondents.   
The research team involved in the analysis of the material was interdisciplinary and consisted 
of five researchers with various background and with experience from different areas such as 
medicine, obstetrics, medical management, organizational change, statistics, and health 
economics. The presence of these different areas of expertise ensured that diverse 
perspectives on the data collected were presented and different views were evaluated to 
achieve a nuanced interpretation of the data.  
5.3 SUGGESTIONS FOR FURTHER RESEARCH 
The analyses of variations in birth care presented here included information on all maternal 
diagnoses during and after delivery but did not include information on diagnoses for the 
newborn in neonatal and paediatric care, which constitutes an important part of the outcome 
in obstetric care. Consequently, neonatal morbidity could not be captured and used as an 
indicator of health outcomes. Transfer to neonatal care units may be used as an indicator of 
neonatal health, but certain local differences in routines for transferring newborns to neonatal 
care units limit the possibilities for using it as a direct indicator of health outcomes. Record-
linkage of mothers and their newborns to capture actual neonatal morbidity would be an 
interesting topic for future studies of variation in childbirth care performance. 
Another interesting topic for future research would be to investigate women’s preferences 
regarding variations in rates for adverse maternal and neonatal outcomes across providers, to 
understand how differences in risk for these adverse outcomes would be weighed against 
each other by patients. One approach to conduct such studies is “stated preference” where 
preferences are elicited through hypothetical scenarios. This could be done by asking women 
which of the different hospitals (with varying risks of adverse events) that they would prefer. 
Another potential research approach is “revealed preference”, where actual individual 
behaviour is used to elicit preferences. In a setting where pregnant women had access to 
publicly reported outcomes data and were able to freely choose their preferred hospital, the 
importance of these outcomes as perceived by the women could be investigated.   
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This thesis studies case mix adjusted variations in Sweden and the results show potential for 
improvement. However, performing similar analysis of risk adjusted variations including 
several countries could potentially reveal differences that are not seen within countries. Given 
that large cross-country differences in factors such as education, culture, and organization, 
variations would be expected to be larger than within-country variations. Moreover, for a 
large university hospital, benchmarking with university hospitals in other countries may 
provide more insights than benchmarking with a small hospital in the same region. The 
challenge would be to identify and define indicators that can be validly compared between 
countries, knowing that the countries can have different coding systems both for diagnosis 
codes and for medical procedures. As discussed in this thesis there are differences in coding 
practices and definitions of conditions between different hospitals and regions in Sweden, and 
such differences are likely more accentuated between countries. Nevertheless, research 
should be performed around the possibilities of international benchmarking and best practice 
sharing across countries.  
One area of research that could be significantly developed is the incorporation of PROMs for 
measurement of performance in the area of birth care. There is evidence that health care 
professionals value PROMs in the clinical decision-making process. However, there are 
barriers to increased use of PROMs, such as a lack technology for capturing this information 
efficiently as well as challenges associated with the presentation and interpretation of the 
data [100]. Nevertheless, recent evidence that use of PROMs is associated with improved 
survival in cancer care further underlines the importance of systematically incorporating the 
patient perspective into measurement of performance [101].  
Beyond capturing additional information from patients, another interesting area of future 
research would be how patients can be involved in performance measurement to a larger 
extent. This could give better information on what the most relevant aspects of measurement 
are from a patient-perspective. More research around how performance data can be reported 
back to patients and not only to health care professionals would also be of great value. Given 
that patients have more limited information about clinical decision making and less 
experience of interpretation of health care performance indicators compared to professionals, 
different ways of presenting data need to be explored and tested with patients.  
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6 CONCLUSION 
6.1 STUDY CONCLUSIONS 
This thesis shows that a broad range of baseline characteristics of women giving birth have a 
large impact on performance indicators in childbirth care. Consequently, sociodemographic 
and clinical maternal characteristics should be accounted for when conducting comparisons 
of performance between hospitals. 
There are significant differences in CS rate between Swedish hospitals. Adjustment for case 
mix has an impact on the ranking of different hospitals but does not remove the large 
variations between hospitals. This indicates that there is a potential for fewer CS in Swedish 
childbirth care and consequently lower resource use. Health outcomes also vary between 
hospitals after adjustment for differences in case mix. The performance of hospitals was not 
the same for different outcome indicators and all hospitals have potential for improvement in 
certain aspects of labour management. 
Another conclusion from this thesis is that technology has the potential to enable systematic 
QI through motivating professionals by providing timely and adequate feedback of 
performance. However, the adoption of such technology is complex and requires openness 
for gradual learning and improvement, and a leadership to engage professionals and other 
stakeholders in solving challenges that arise throughout the adoption process.  
6.2 POLICY RECOMMENDATIONS FOR PERFORMANCE MEASUREMENT 
Given the extensive literature available and the findings of the studies in this thesis, there are 
several recommendations that should be considered in relation to performance measurement: 
• Involve health care professionals and other stakeholders in the selection and definition 
of performance measures to ensure that they feel ownership over indicators. 
• Enable health care professionals by giving them access to frequently updated and 
reliable information about their performance for use in continuous quality 
improvement. 
• Ensure measurement of several types of indicators to ensure relevance for all 
stakeholders in the health care system: both patient relevant outcome measures and 
measures of the care process. 
• Harmonize selection and measurement of indicators across hospitals, regions, and, if 
possible, nations to enable benchmarking and identification of best practice. 
• When explicit financial incentives are introduced, make sure that they align with 
overall goals of the health care systems and that they do not conflict with the inner 
motivation of health care professionals. Also put processes in place to monitor 
development over time, to ensure that gaming does not occur and that unintended 
consequences do not appear. 
• Put effort into statistical analysis to ensure reliability and validity of performance 
measures and employ case mix adjustment in interhospital comparisons. This is 
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important for acceptance among professionals and for understanding true 
improvement potential. 
• Ensure accessible presentation of statistical data so that all stakeholders can draw 
appropriate conclusions. 
• Support leaders in health care to create conditions for systematic quality improvement 
and to help them understand how they can motivate staff through use of data. 
• Increase the understanding in health care organizations of the complexity associated 
with using technology to support quality improvement so that they have a strategy for 
dealing with challenges that arise throughout the adoption process. 
There are also several additional recommendations specifically for birth care that are relevant 
to consider:  
• Perform measurement of CS rate because it is linked to several indicators of health 
outcomes and resource use. 
• Also ensure systematic measurement of other indicators than CS to get a good 
understanding of entire care process and the health outcomes. 
• Collect information about PROMs and PREMs in relation to childbirth as these are 
fundamental factors to understand both short- and long-term outcomes. 
• Use a broad spectrum of indicators of case mix (e.g. demographic information, 
reproductive history, other obstetric factors, and comorbidities) to adjust analyses of 
performance. 
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Fokusgruppintervjuer med deltagare i 




Personal på kvinnokliniken på Akademiska sjukhuset i Uppsala. 
Inledningstext 
Syftet med detta projekt är att öka förståelsen om hur hälso- och sjukvårdsorganisationer kan 
utveckla sin förmåga att öka kvaliteten med hjälp av datadrivet förbättringsarbete.  
Forskningsprojektet ämnar studera pågående datadrivna förbättringsarbeten i Uppsala och 
Stockholm. Vi avser att kunna få en djupare förståelse för hur dessa förbättringsansatser 
genomförs i praktiken samt att identifiera hindrande och underlättande faktorer i 
förbättringsansatserna utifrån ert perspektiv. 
Avsikten med projektet är att utveckla konkreta förslag till utveckling av effektiva sätt att förbättra 
hälso- och sjukvården.  
Intervjun kommer att ta max 90 minuter. Intervjufrågorna handlar om vad datadrivet 
förbättringsarbete innebär, hur ni arbetar med datadriven förbättring, hur ni arbetade tidigare 
med förbättringsarbete, vilken typ av data ni använder, vilka utmaningar ni ser med att arbeta på 
det här sättet och vilka fördelar ni ser. 
Vi har valt en gruppintervju av två anledningar: 1) för att ta mindre tid från ert patientarbete och 
2) vi är intresserad av hur ni arbetar på kliniknivå med förbättringsarbete och inte på individnivå. 
Därför kommer vi att analysera på gruppnivå, personal, chefer.  
Frågorna är öppna för att ni ska kunna beskriva era tankar fritt. Deltagandet är frivilligt. Ni kan 
närsomhelst välja att avbryta intervjun. All data kommer att behandlas konfidentiellt och 
inspelningarna kommer att raderas efter transkribering. Deltagandet i intervjun är anonymt på det 
sättet att ni inte kommer nämnas vid namn i något producerat dokument. Endast vår forskargrupp 
på MMC kommer att ha tillgång till intervjumaterialet. Vi kommer att sammanfatta resultaten i en 
vetenskaplig artikel.  
För att underlätta analysarbetet kommer intervjun att spelas in. Är det ok för er?  






1. Skulle ni kunna kort berätta om vilka ni är (profession, roll i organisationen, hur länge du 
har jobbat här)?  
Kvalitetsarbete generellt 
2. Skulle ni kunna berätta hur ni jobbar för att förbättra vården för era patienter?  
a. Beskriv konkret? Vad innebär det?  
b. Finns det någon särskild metod ni använder er av? 
c. Har ert sätt att arbeta med förbättring förändrats under de senare åren? 
d. Finns det någon särskild patientgrupp som ni fokuserar på (condition)?  
3. Hur mäter ni och följer upp den vård som ni bedriver?  
a. Vilken data?  
Technology (data & plattformen)  
Som vi förstår så har det pågått ett arbete för att följa upp kvalitetsarbete på ett systematiskt och 
digitaliserat sätt på er klinik, med hjälp av TV-vyn?  
4. Hur använder ni plattformen?  
a. Vilken data använder ni? 
b. Hur använder ni data?  
5. Vilken kunskap/information får ni via data/plattformen? (OBS! kanske överflödigt)  
6. Vilken kunskap behövs det för att använda data/plattformen?  
7. Vilket stöd behövs det för att använda data/plattformen? (det som finns och saknas) 
Value proposition and value chain (programteori)  
Om vi blickar tillbaka då er klinik började arbeta med plattformen.  
8. Varför började kliniken använda data och plattformen?  
a. Men dina egna ord, vilket problem försökte ni att lösa med dessa?  
b. Vilket behov fanns det? (committment)  
c. Vilka resultat förväntade ni er?  
9. Värdebaserad vård syftar att utveckla bättre metoder för att mäta och följa upp värde i 
vården med ambitionen att åstadkomma bästa tänkbara hälsoutfall för patienter. Hur 
anser ni att denna ambition har förverkligats i praktiken?  
Adopter system  
10. Har data och plattformen förändrat ert sätt att med jobba med förbättringsarbete?  
a. Har ni använt någon vedertagen modell för projektet? 
b. Hur har chefernas arbete förändrats? 
c. Hur har medarbetares arbete förändrats?  
d. Vilka resultat har ni observerat för patienter?  
i. Är det någon särskild patientgrupp/område där ni har fått mest nytta av 
data/plattformen? 
e. Hur har samarbete med andra aktörer förändrats? T.ex. andra klinker på 
sjukhuset, andra vårdgivare, landsting?  
11. Vilka fördelar har ni upplevt mot tidigare sätt att arbeta med förbättring?  
12. Vilka utmaningar har ni upplevt mot tidigare sätt att arbeta med förbättring?  
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Organization 
13. Hur gick införandet av plattformen till?  
a. Vilka var nyckelpersoner?  
b. Hur upplevde ni införandet av plattformen? (committment) 
14. Hur såg förutsättningarna ut för att ni skulle kunna arbeta med den här plattformen 
(t.ex. resurser, stöd, tid, kompetens)? (efficacy) 
Wider system  
15. Hur påverkar yttre faktorer, till ex. policy, krav från beställaren, hur ni arbetar med 
data/plattformen?  
Embedding and adoption over time  
16. Vad har ni lärt er av arbetet och användning av data/plattformen?  
17. Hur har arbetet och användningen av plattformen utvecklas över tid? Har ni behövt göra 
några förändringar?  
 
